Diagnosing MS

Most patients with probable MS will progress rapidly to definite MS.


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, Aug 1 (Praxis Press) A definite diagnosis of multiple sclerosis (MS) can only be reached after the second neurologic relapse occurs. Therefore, between the first and second relapse, patients are classified as having probable MS. To investigate the rate of progression from probable to clinically definite MS, Achiron and colleagues performed a 7-year prospective study of 163 patients experiencing their first episode of neurologic symptoms suggestive of MS. They found that within the follow-up period (mean, 42 months), 136 patients had an additional relapse and were therefore defined as having clinically definite MS, whereas 27 patients were defined as having clinically probable MS. The researchers also analyzed demographic and clinical parameters at presentation to identify variables predictive of rapid progression (within one year) to clinical definite MS. Motor involvement at onset was the only clinical parameter associated with rapid progression to a definite diagnosis. Polysymptomatic involvement and higher ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo